Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Glenview Capital Is Quite The Healthcare Bull: Life Technologies Corp. (LIFE), Thermo Fisher Scientific Inc. (TMO) & More

Larry Robbins is the founder of Glenview Capital. Prior to founding the hedge fund in 2001, Larry Robbins worked as a trader at Omega Advisors, managed by Leon Cooperman.

GLENVIEW CAPITALThe 13F form, filed with the Securities and Exchange Commission on a quarterly basis, can help us take a look at aggregate and individual levels of hedge fund sentiment. Empirical studies have discovered that by following the sentiment of a particular subset of hedge funds, retail investors can outperform the broader indices by about 18 percentage points per year, over a long-term period.

With that in mind, let’s take a look at Glenview’s top five stock picks for the past quarter.

In first is Life Technologies Corp. (NASDAQ:LIFE). The hedge fund disclosed ownership of 10.2 million shares of the company, with the value of the stake amounting to $755.3 million. In comparison with the first quarter of the year, Glenview’s stake in Life Technologies Corp. (NASDAQ:LIFE) declined by over 4.3 million shares. Since the beginning of the year, the stock has returned over 52%, and at the same time, it sports a forward P/E of about 16.4x and a PEG ratio of 3.12.

At No. 2 is Thermo Fisher Scientific Inc. (NYSE:TMO). During the second quarter of the year, Glenview’s stake in Thermo Fisher Scientific Inc. (NYSE:TMO) included 8.5 million shares, and was worth about $720.1 million. The position of the hedge fund in Thermo Fisher surged during the quarter by more than 5.3 million, with the previous value of the stake amounting to $244.9 million. The stock has a year-to-date return of almost 44%.

In addition to the aforementioned companies, Glenview also disclosed a large stake in Health Management Associates Inc (NYSE:HMA). The stake amounts to $593.6 million and contains 37.8 million shares, unchanged over the quarter. In McKesson Corporation (NYSE:MCK), the hedge fund’s position contains 4.3 million shares, and is worth $488.2 million, an increase of 552,663 shares since the end of March. And in its fifth-largest stake, Glenview Capital disclosed it was long Flextronics International Ltd. (NASDAQ:FLEX): almost 59.1 million shares worth, up by 7 million shares over the quarter.

We’ll keep you updated on Glenview and the rest of funds’ filings during 13F season.

Recommended reading: General Motors Company (GM), Taiwan Semiconductor Mfg. Co. Ltd. (TSM): The Legendary Richard Driehaus Is Bullish Here

Loading Comments...